As the complexity of the p53 responses observed and the network of players is constantly growing and is far from being disentangled, research on the most studied tumor-suppressor gene needs to continue to provide satisfactory context- and cell-type-dependent answers that will eventually help to harness p53 for cancer treatment. This evidence concerns the gene TP53 and cancer.